Site 0126 - Wilmot Cancer Center — Rochester, New York

Site 0126 - Wilmot Cancer Center is a clinical research site located in Rochester, New York, United States 14642.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 0126 - Wilmot Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rochester

Browse all research sites in New York · View every site in Rochester

• University of Rochester Medical Center, Alzheimer's Disease Center
• University of Rochester Medicine Otolaryngology
• University of Rochester, Eastman Dept of Dentistry
• Golisano Children's Hospital at Strong
• University of Rochester Medical Center/Flaum Eye Institute
• University of Rochester Sleep Research Laboratory
• University of Rochester Medical Center /ID# 213527
• University of Rochester, Department of Neurology
• University of RochesterJames P. Wilmont Cancer Center
• University Radiation Oncology
• Rochester General Hospital's Lipson Cancer and Blood Center
• Multiple Sclerosis Center, University of Rochester Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0126 - Wilmot Cancer Center?

Site 0126 - Wilmot Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0126 - Wilmot Cancer Center conducted?

Site 0126 - Wilmot Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0126 - Wilmot Cancer Center accredited by Crixeo Clinical Trials?

Site 0126 - Wilmot Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0126 - Wilmot Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.